{"id":"tp-32145","type":"article-newspaper","title":"Nvidia-Backed Iambic Therapeutics Prices IPO at $16 a Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/32145","datePublished":"2026-10-15T00:42:20.000Z","dateModified":"2026-10-15T00:42:20.000Z","language":"en","abstract":"The AI drug developer is offering about 9.38 million shares and expects to begin trading on Nasdaq on Oct. 15 under ticker IAM.","section":"Business","references":[{"title":"Iambic's earlier Nasdaq plan","url":"https://www.tokenpost.com/news/business/28101"}]}